Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
Sanofi, Novo Nordisk, Bristol-Myers Squibb, GSK, Eli Lilly are the leader of the industry, and hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Glucagon Like Peptide-1 (GLP-1) Agonists market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Glucagon Like Peptide-1 (GLP-1) Agonists market. Detailed analysis of key players, along with key growth strategies adopted by Glucagon Like Peptide-1 (GLP-1) Agonists industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
Novo Nordisk
Bristol-Myers Squibb
GSK
Eli Lilly
AstraZeneca
Amylin
By Type:
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
By End-User:
Hospital
Pharmacy
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists Market
-
1.3 Market Segment by Type
-
1.3.1 USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Exenatied from 2016 to 2027
-
1.3.2 USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Liraglutide from 2016 to 2027
-
1.3.3 USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Lixisenatide from 2016 to 2027
-
1.3.4 USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Albiglutide from 2016 to 2027
-
1.3.5 USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Dulaglutide from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Pharmacy from 2016 to 2027
-
1.4.3 USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Glucagon Like Peptide-1 (GLP-1) Agonists Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Glucagon Like Peptide-1 (GLP-1) Agonists by Major Types
-
3.4.1 Market Size and Growth Rate of Exenatied
-
3.4.2 Market Size and Growth Rate of Liraglutide
-
3.4.3 Market Size and Growth Rate of Lixisenatide
-
3.4.4 Market Size and Growth Rate of Albiglutide
-
3.4.5 Market Size and Growth Rate of Dulaglutide
4 Segmentation of Glucagon Like Peptide-1 (GLP-1) Agonists Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Glucagon Like Peptide-1 (GLP-1) Agonists by Major End-Users
-
4.4.1 Market Size and Growth Rate of Glucagon Like Peptide-1 (GLP-1) Agonists in Hospital
-
4.4.2 Market Size and Growth Rate of Glucagon Like Peptide-1 (GLP-1) Agonists in Pharmacy
-
4.4.3 Market Size and Growth Rate of Glucagon Like Peptide-1 (GLP-1) Agonists in Other
5 Market Analysis by Regions
-
5.1 USA Glucagon Like Peptide-1 (GLP-1) Agonists Production Analysis by Regions
-
5.2 USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis
-
6.1 West USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis by Major Types
-
6.2 West USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis by Major End-Users
7 South USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis
-
7.1 South USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis by Major Types
-
7.2 South USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis by Major End-Users
8 Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis
-
8.1 Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis by Major Types
-
8.2 Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis by Major End-Users
9 Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis
-
9.1 Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis by Major Types
-
9.2 Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Sanofi
-
10.1.1 Sanofi Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Novo Nordisk
-
10.2.1 Novo Nordisk Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Bristol-Myers Squibb
-
10.3.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 GSK
-
10.4.1 GSK Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Eli Lilly
-
10.5.1 Eli Lilly Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 AstraZeneca
-
10.6.1 AstraZeneca Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Amylin
-
10.7.1 Amylin Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Exenatied from 2016 to 2027
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Liraglutide from 2016 to 2027
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Lixisenatide from 2016 to 2027
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Albiglutide from 2016 to 2027
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Dulaglutide from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Pharmacy from 2016 to 2027
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Glucagon Like Peptide-1 (GLP-1) Agonists Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Glucagon Like Peptide-1 (GLP-1) Agonists
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Different Types from 2016 to 2027
-
Table Consumption Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Exenatied
-
Figure Market Size and Growth Rate of Liraglutide
-
Figure Market Size and Growth Rate of Lixisenatide
-
Figure Market Size and Growth Rate of Albiglutide
-
Figure Market Size and Growth Rate of Dulaglutide
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Different End-Users from 2016 to 2027
-
Table Consumption Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Pharmacy
-
Figure Market Size and Growth Rate of Other
-
Table USA Glucagon Like Peptide-1 (GLP-1) Agonists Production by Regions
-
Table USA Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Regions
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Regions in 2016
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Regions in 2021
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Regions in 2027
-
Table USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Regions
-
Table USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Regions
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Regions in 2016
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Regions in 2021
-
Figure USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Regions in 2027
-
Table West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Types from 2016 to 2027
-
Table West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types from 2016 to 2027
-
Figure West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2016
-
Figure West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2021
-
Figure West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2027
-
Table West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by End-Users from 2016 to 2027
-
Table West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2016
-
Figure West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2021
-
Figure West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2027
-
Table South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Types from 2016 to 2027
-
Table South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types from 2016 to 2027
-
Figure South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2016
-
Figure South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2021
-
Figure South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2027
-
Table South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by End-Users from 2016 to 2027
-
Table South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2016
-
Figure South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2021
-
Figure South USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2027
-
Table Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Types from 2016 to 2027
-
Table Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2016
-
Figure Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2021
-
Figure Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2027
-
Table Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2016
-
Figure Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2021
-
Figure Middle West USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2027
-
Table Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Types from 2016 to 2027
-
Table Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2016
-
Figure Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2021
-
Figure Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by Types in 2027
-
Table Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2016
-
Figure Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2021
-
Figure Northeast USA Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of GSK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK
-
Figure Sales and Growth Rate Analysis of GSK
-
Figure Revenue and Market Share Analysis of GSK
-
Table Product and Service Introduction of GSK
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Amylin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amylin
-
Figure Sales and Growth Rate Analysis of Amylin
-
Figure Revenue and Market Share Analysis of Amylin
-
Table Product and Service Introduction of Amylin
-
